By Fineline Cube China-based infrastructure investor DNE Group has revealed that it has raised a new fund worth over RMB 3.5 billion (USD 485 million) to establish a life sciences park in Shanghai’s Pudong district. The fund, which was opened in Q1 2023, is reportedly backed primarily by China-based insurance companies. The project, invested in by the Fund, is situated in a core industry cluster in the Shanghai Pudong area and is designed to provide high-quality R&D facilities to leading domestic and foreign life sciences enterprises.
DNE Group’s Strong Track Record in Life Sciences Investments
DNE Group has a robust track record in life sciences investments, with a current portfolio that includes the operation and management of life sciences parks covering over 700,000 square meters in Shanghai and the Yangtze River Delta region. The company is also looking ahead with over 1.5 million square meters of future projects already in the pipeline, demonstrating its commitment to fostering innovation and growth in the life sciences sector.-Fineline Info & Tech